May 16, 2023 02:22 PM EDT
Pharma
Manufacturing

Ip­ca Lab­o­ra­to­ries cit­ed for qual­i­ty is­sues at In­dia fa­cil­i­ty that pro­duces API

Tyler Patchen

News Reporter

The FDA iden­ti­fied sev­er­al qual­i­ty is­sues at a plant in In­dia owned by Ip­ca Lab­o­ra­to­ries that makes ac­tive phar­ma­ceu­ti­cal in­gre­di­ents.

In the

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pfiz­er’s RSV vac­cine has 90% ef­fi­ca­cy against se­vere res­pi­ra­to­ry dis­ease

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times